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ABSTRACT
In this study, we report the biochemical characteriza-
tion of the deafness-associated mitochondrial 12S
rRNA C1494T mutation using 27 cybrid cell lines con-
structedbytransferringmitochondriafrom9lympho-
blastoid cell lines derived from a Chinese family into
humanmitochondrialDNA(mtDNA)-less(r )cells.Six
cybrids derived from two asymptomatic members,
and nine cybrids derived from three symptomatic
members of the Chinese family carrying the C1494T
mutation exhibited  38 and 43% decrease in the rate
of mitochondrial protein labeling, respectively, com-
pared with twelve cybrids derived from four Chinese
control individuals. These defects are apparently
a primary contributor to significant reductions in
the rate of overall respiratory capacity or the rate
of malate/glutamate promoted respiration, or succi-
nate/G3P-promoted respiration, or TMPD/ascorbate-
promoted respiration in mutant cybrid cell lines
derived from either symptomatic or asymptomatic
individuals. Furthermore, the very significant/nearly
identical increase in the ratio of doubling times in
DMDM medium in the presence/absence of high con-
centration of paromomycin was observed in sympto-
matic or asymptomatic cybrid cell lines carrying the
C1494T mutation as compared with the average rate
in control cell lines. These observations provide the
direct biochemical evidences that the C1494T muta-
tion is a pathogenic mtDNA mutation associated with
aminoglycoside-inducedandnon-syndromichearing
loss. In addition, these data provide the first bio-
chemical evidence that nuclear background plays a
critical role in the phenotypic manifestation of non-
syndromic hearing loss and aminoglycoside toxicity
associated with the C1494T mutation.
INTRODUCTION
Mutations in mitochondrial DNA (mtDNA) have been found
to be associated with both syndromic and non-syndromic
forms of sensorineural hearing impairment (1,2). The mito-
chondrial tRNA
Ser(UCN) appears to be a hot spot for mtDNA
mutations associated with non-syndromic hearing loss. Four
deafness-associated mutations, A7445G (3,4), 7472insC (5,6),
T7510C (7,8) and T7511C (9,10), have been identiﬁed in this
gene. The mitochondrial 12S rRNA is another hot spot for
mtDNA mutations associated with aminoglycoside induced
and non-syndromic hearing loss. Of those, the homoplasmic
A1555G mutation in the highly conserved decoding site of this
rRNA has been associated with aminoglycoside-induced and
non-syndromic hearing loss in many families of different
ethnic backgrounds (11–18). In addition, mutations at position
961 of the 12S rRNA have been implicated to be associated
with aminoglycoside-induced and non-syndromic hearing loss
(19–22). Furthermore, the T1095C mutation inthe same rRNA
has also been shown to be associated with hearing impairment
(23,24). Most recently, the homoplasmic C1494T mutation
in the highly conserved decoding site of this rRNA has
been associated with both aminoglycoside-induced and non-
syndromic hearing loss in a large Chinese family (25).
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doi:10.1093/nar/gki262As shown in Figure 1, the C1494T mutation is located in the
decoding region of the small ribosomal subunit (26), highly
conserved from bacteria to mammals (27). The same region is
important for the action of aminoglycosides (28,29). In fact,
the C1494T mutation is expected to form a novel 1494U–
A1555 base pair, which is in the same position as the
1494C–G1555 pair created by the A1555G mutation, at the
highly conserved A-site of 12S rRNA (25). In fact, the new
U–A or G-C pair in 12S rRNA created by the C1494T or
A1555G transition facilitates the binding of aminoglycosides
(30,31), accounting for the fact that the exposure to
aminoglycosides can induce or worsen hearing loss in indi-
viduals carrying these mutations (11,25,32). In the absence of
aminoglycosides, matrilineal relatives in this Chinese family
carrying the C1494T mutation exhibited non-syndromic sen-
sorineural hearing loss with a wide range of the age of onset
and severity, ranging from severe hearing impairment, to
moderate hearing impairment, to mild hearing impairment,
to completely normal hearing (25). To elucidate pathogenetic
mechanism of the C1494T mutation and the role of nuclear
background in the phenotypic expression of this mutation,
cybridcelllineswere constructedbytransferringmitochondria
from lymphoblastoid cell lines derived from three sympto-
matic individuals and two asymptomatic individuals in this
Chinese family and from four controls into human mtDNA-
less (r ) cells (33,34). These cybrid cell lines were ﬁrst
examinedforthepresence anddegreeofthe C1494T mutation.
These cell lines were then assessed for the effects of the
C1494T mutation on the rate of mitochondrial protein syn-
thesis, the endogenous respiration and substrate-dependent
respiration, and the growth properties after treatment with
aminoglycoside.
MATERIALS AND METHODS
Cell lines and culture conditions
A total of nine human immortalized lymphoblastoid cell lines
derived from the members of the Chinese family [two asymp-
tomatic members (III-14 and III-16) and three symptomatic
members (III-18, IV-21 and IV-28) and four genetically
unrelated Chinese control subjects (A3, A6, A7 and A8)
(25) were grown in RPMI 1640 medium (Invitrogen), supple-
mented with 10% fetal bovine serum (FBS). The bromodeoxy-
uridine (BrdU)-resistant osteosarcoma 143B.TK
  and cybrid
cell line F7H derived from an Arab–Israeli family carrying the
A1555G mutation (35) as grown in DMEM, supplemented
with 100 mg of BrdU per ml and 5% FBS. The mtDNA-
less r 206 cell line, derived from 143B.TK
  (33), was
grown under the same conditions as the parental line, except
for the addition of 50 mg of uridine per ml. All cybrid cell lines
constructed with enucleated lymphoblastoid cell lines were
maintained in the same medium as the 143.TK
  cell line.
To test the various cell lines for sensitivity to paromomycin,
samplesof10
5cells were platedandthengrownon10cmPetri
dishes in 10 ml of DMEM (Invitrogen), supplemented with
10% FBS, in the presence or absence of 2 mg of the antibiotics
per ml. The population doubling time (DT) of the cell lines in
DMEM medium, supplemented with 10% dialyzed FBS, was
determined from the growth curves or by using the formula
(36): DT = (t   t0)log2/(logN   logN0), where t and t0 are the
timesatwhich thecells were counted,andNandN0arethe cell
numbers at times t and t0, respectively.
Mitochondria-mediated r 206 cell transformation
Immortalized lymphoblastoid cell lines derived from ﬁve
matrilineal relatives [two asymptomatic members (III-14
and III-16) and three symptomatic members (III-18, IV-21
and IV-28)] of the Chinese family and four genetically unre-
lated control individuals were usedfor the generationof cybrid
cell lines (25). Transformation by cytoplasts of mtDNA-
less r 206 cells was performed as described previously
(33–35,37,38).
Mitochondrial DNA analysis
The analysis of the presence and level of the C1494T mutation
in the mitochondrial 12S rRNA was carried out as described
previously (25). The quantiﬁcation of mtDNA copy numbers
from different cybrids was performed by slot-blot hybridiza-
tion as detailed previously (36).
Figure 1. ThelocationoftheC1494TmutationinthedecodingregionofsmallribosomalRNAs.TheA-siteofhumanmitochondrial12SrRNAisshownasthewild
type version (A) and the version containing the A1555G mutation (B) and C1494T mutation (C), respectively. The sites for the A1555G or C1494T mutation are
indicated by arrows.
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Pulse-labeling of the cell lines for 30 min with
[
35S]methionine–[
35S]cysteine in methionine-free DMEM in
the presence of emetine, electrophoretic analysis of the trans-
lation products, and quantiﬁcation of radioactivity in the
whole-electrophoretic patterns or in individual well-resolved
bands was carried out as detailed previously (36,37,39,40).
O2 consumption measurements
Ratesof O2consumptioninintactcellsweredeterminedwith a
YSI 5300 oxygraph (Yellow Springs Instruments) on samples
of 5 · 10
6 cells in 1.5 ml of special DMEM-glucose lacking
glucose, and supplemented with 10% dialyzed FBS (33).
Polargraphic analysis of digitonin-permeabilized cells, using
different respiratory substrates and inhibitors, to test the
activity of the various respiratory complexes was carried
out as detailed previously (41).
Computer analysis
Variance analysis was performed by the Student’s t-test
contained in the Microsoft Excel program for Macintosh
(version 5), entering individual replicate values. Correlation
analysis was performed using the curve ﬁtting in CA-Cricket
Graph III(tm) program for Macintosh (version 1.5.2).
RESULTS
Construction of cybrid cell lines
Lymphoblastoid cells derived from four control individuals
(A3, A6, A7 and A8), aged between 20 and 40 years, and
from two asymptomatic members (III-14 and III-16) and
three symptomatic members (III-18, IV-21 and IV-28) of
the Chinese family (25) were enucleated, and subsequently
fused to a large excess of mtDNA-less human r 206 cells,
derived from the BrdU-resistant 143B.TK
  cell line (33).
Cybrid clones were isolated by growing the fusion mixtures
in selective DMEM medium, containing BrdU and lacking
uridine (34,35,37,38). Between 25 and 45 days after fusion,
10–15presumptivemitochondrialcybridsderivedfromeachof
the different donor cell lines were isolated, and subsequently
analyzed for the presence and level of the C1494T mutation
(25). The results conﬁrmed the absence of the C1494T muta-
tion in control cybrids and its presence in homoplasmy in
mutant cybrids. An analysis of the mtDNA content of these
cybrids by slot-blot hybridization was performed using the
DIG-labeled mt12S rRNA, and nuclear 28S rRNA probes
for normalization purposes (36,37). Three cybrids derived
from each donor lymphoblastoid cell line with similar
mtDNA copy number were used for the biochemical charac-
terization described below.
Mitochondrial protein synthesis defect in the cybrid
cell lines
To examine whether a defect in mitochondrial translation
occurred in cybrids carrying the C1494T mutation, cells
from three cybrids derived from each donor of four control
individuals and each donor of two asymptomatic and three
symptomatic members of the Chinese family were labeled for
30 min with [
35S]methionine–[
35S]cysteine in methionine-free
regular DMEM medium in the presence of 100 mg/ml of
emetine, to inhibit cytosolic protein synthesis (39). Figure 2
shows typical electrophoretic patterns of the mitochondrial
translation productsof the mutant and control cybrids. Patterns
of the mtDNA-encoded polypeptides of the mutation-carrying
cybridswerequalitatively identical,intermsofelectrophoretic
mobility of the various polypeptides, to those of the control
cybrids and of 143B.TK
  cells (Figure 2A and B). However,
cybridscarryingtheC1494Tmutationshowedacleartendency
to a decrease in the total rate of labeling of the mitochondrial
translation products, relative to those of control cybrids.
Figure 3 shows a quantiﬁcation of the results of a large
number of labeling experiments and electrophoretic runs,
which were carried out by densitometric analysis of appropri-
ate exposures of the ﬂuorograms and normalization to data
obtained for the 143B.TK
  sample included in each gel. It
appears that the overall rate of labeling of the mitochondrial
translation products in mutant cybrids derived from sympto-
matic individuals was decreased by 37–48%, with an average
of 43%, relative to the mean value measured in the control
cell lines (P = 0.0006). Similarly, the reduction in the rate of
labeling of the same products in the mutant cybrids derived
from asymptomatic individuals ranged from 34 to 43%, with
an average of 38% (P = 0.0197). It is noteworthy that the
decreased levels of mitochondrial protein labeling in cybrid
cells carrying the C1494T mutation are comparable with
 35% average reduction in the rate of labeling of the same
products observed in F7H, a cybrid cell line carrying the
A1555G mutation.
Respiration defects in the cybrid cell lines
Theendogenous respiration rates ofthreecybrids derived from
each of four control individuals and each of two asymptomatic
and three symptomatic members of the Chinese family carry-
ing the C1494T mutation were measured by determining the
O2 consumption rate in intact cells, as described previously
(33). As shown in Figure 4, the rate of total O2 consumption in
the cybrids derived from three symptomatic individuals exhib-
ited a variable decrease, ranging between  35 and 47%, with
an average reduction of  41% relative to the mean value
measured in the control cell lines (P = 0.0017). Cybrids
derived from two asymptomatic individuals also revealed
a variable decrease in O2 consumption rate, ranging between
33 and 37%, when compared to the mean control value, with
an average reduction of  35% (P = 0.0095). The variations in
the overall respiration rate among the individual mutant
cybrids derived from symptomatic members of the Chinese
family, and, similarly, among the mutant cybrids derived
from asymptomatic members, as compared with the individual
control cybrids, showed a very signiﬁcant correlation with
the corresponding variations in the overall rate of labeling
of mitochondrial protein synthesis (r = 0.98, P < 0.001;
r = 0.99, P < 0.001, respectively).
In order to investigate which of the enzyme complexes
of the respiratory chain was affected in the mutant cell lines,
O2 consumption measurements were carried out on digitonin-
permeabilized cells, using different substrates and inhibitors
(41). As shown in Figure 5, in the cybrids derived from three
symptomatic individuals, the rate of malate/glutamate-driven
1134 Nucleic Acids Research, 2005, Vol. 33, No. 3respiration, which depends on the activities of NADH:ubiqui-
noneoxidoreductase(ComplexI),ubiquinol–cytochromecred-
uctase (Complex III) and cytochrome c oxidase (Complex IV),
but usually reﬂects the rate-limiting activity of Complex I
Figure2.Electrophoreticpatternsofthemitochondrialtranslationproductsofcybridsandof143B.TK
 cellslabeledfor30minwith[
35S]methionineinthepresence
of 100 mg/ml of emetine. Samples containing equal amounts of protein (20 mg) were run in SDS/polyacrylamide gradient gels. The two panels represent
electrophoretic patterns obtained in separate gel runs, each one including the 143B.TK
  control for normalization purposes. COI, COII and COIII, subunits I,
II and III of cytochrome c oxidase; ND1, ND2, ND3, ND4, ND4L, ND5 and ND6, subunits 1, 2, 3, 4, 4L, 5 and 6 of the respiratory chain NADH dehydrogenase;
A6 and A8, subunits 6 and 8 of the H
+-ATPase; and CYTb, apocytochrome b.
Figure3.Quantificationoftheratesoflabelingofthemitochondrialtranslation
products,aftera30min[
35S]methioninepulse,incybridsderivedfromdifferent
donor lymphoblastoid cell lines. The rates of mitochondrial protein labeling,
determined as detailed in Materials and Methods, are expressed as percentages
ofthevaluefor143B.TK
 ineachgel,witherrorbarsrepresentingtwostandard
errors of the mean (SE). A total of 2–3 independent labeling experiments and
2–4 electrophoretic analyses of each labeled preparation were carried out
on three cybrids derived from each donor lymphoblastoid cell line. C, control;
AS,asymptomaticindividuals;andS,symptomaticindividuals.Thehorizontal
dashedlinesrepresenttheaveragevalueforeachgroup,andtheverticalarrows
refertotwoSE;Pindicatesthesignificance,accordingtotheStudent’st-test,of
thedifferencesbetweenASmeanandCmean,andbetweenSmeanandCmean.
Figure 4. Average rates of endogenous O2 consumption per cell measured
in different cybrids are shown, with error bars representing two SE. A total of
4–6determinationsweremadeoneachofthreecybridsderivedfromeachdonor
lymphoblastoidcellline.Graphdetailsandsymbolsareexplainedinthelegend
to Figure 3.
Nucleic Acids Research, 2005, Vol. 33, No. 3 1135(41,42), was very signiﬁcantly decreased, relative to the
average rate in the control cell lines, by 39–51% ( 44% on
the average; P = 0.0004). Similarly, the rate of succinate/
glycerol-3-phosphate (G3P)-driven respiration, which
depends on the activities of Complexes III and IV, but usually
reﬂects the rate-limiting activity of Complex III, was signi-
ﬁcantly affected, relative to the average rate in the control
cell lines, by 34–50% ( 41% on the average; P = 0.0021);
furthermore, the rate of N,N,N0,N0-tetramethyl-p-phenylene-
diamine (TMPD)/ascorbate-driven respiration, which reﬂects
the activity of Complex IV, exhibited a 32–44% reduction
in Complex IV activity ( 37% on the average; P = 0.0012).
The corresponding rates in cybrids derived from asympto-
matic individuals were also reduced relative to those from
the control cybrids. These decreases were only slightly
lower than those observed in the cybrids derived from symp-
tomatic individuals, i.e. 36–43%, with  39% on the average
(P = 0.0044), for malate/glutamate promoted respiration;
29–39%, with  34% on the average (P = 0.0263), for
succinate/G3P-promoted respiration; and 28–30%, with
 29% on the average (P = 0.0023), for TMPD/ascorbate-
promoted respiration. The variations in the rates of malate/
glutamate-driven,succinate/G3P-drivenandTMPD/ascorbate-
driven respiration among the individual mutant cybrids
derived from symptomatic subjects, as compared with the
individual control cybrids, showed a signiﬁcant correlation
withthe corresponding variations inthe overall rateof labeling
ofmitochondrialproteinsynthesis(r=0.98,P<0.001;r=0.97,
P < 0.001; r = 0.98, P < 0.001, respectively). Similarly, the
variations in the rates of malate/glutamate-driven, succinate/
G3P-driven and TMPD/ascorbate-driven respiration among
the individual mutant cybrids derived from asymptomatic sub-
jects, as compared with the individual control cybrids, showed
a signiﬁcant correlation with the corresponding variations in
the overall rate of labeling of mitochondrial protein synthesis
(r = 0.99, P < 0.001; r = 0.98, P < 0.001; r = 0.98, P < 0.001,
respectively).
Growth properties of cybrid cell lines after treatment
with aminoglycoside
To examine the role of the C1494T mutation in the effect of
aminoglycoside on the cell growth, three cybrids derived from
each donor of ﬁve individuals carrying the C1494T mutation
andfromeachdonoroffourcontrolslackingthemutationwere
grown in DMEM medium in the presence of aminoglycoside
paromomycin or in its absence for four days. As shown in
Figure 6, in the presence of 2 mg paromomycin per ml, the
growth rates of the mutant cybrids carrying the C1494T muta-
tion exhibited a signiﬁcant/uniform average decrease, relative
to the growth rates of controls cybrids. In particular, in the
mutant cybrids carrying the C1494T mutation, the ratios of
DTsinthepresenceandabsenceofparomomycininthemutant
celllineswereincreasedby29–33%,withanaverageof30.5%,
relativetotheaverage DTratio incontrolcybrids (P<0.0001).
This DT ratio in the C1494T mutation-carrying cells was
comparable with that of cybrid cell line F7H carrying the
A1555G mutation. From these data, we conclude that the
C1494T mutation plays a critical role in the sensitivities to
the aminoglycoside of the growth rate of the cybrid cell
lines derived from matrilineal relatives of this Chinese family.
Figure 5. Polarographic analysis of O2 consumption in digitonin-
permeabilized cells of the various cell lines using different substrates and
inhibitors. The activities of the various components of the respiratory chain
were investigated by measuring on  5 · 10
6 digitonin-permeabilized cells the
respiration dependent on malate/glutamate, on succinate/G3P and on TMPD/
ascorbate. A total of 2–4 determinations were made on each of the three cybrid
cell lines derived from each donor lymphoblastoid cell line. Graph details and
symbols are explained in the legend to Figure 3. mal/glu, malate/glutamate-
dependent respiration; succ/G-3-P, succinate/G3P-dependent respiration; and
asc/TMPD, TMPD/ascorbate-dependent respiration.
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In the present study, we have investigated the pathogenetic
mechanism of the deafness-associated mitochondrial 12S
rRNA C1494T mutation in a large Chinese family using osteo-
sarcoma cell cybrids. Under a constant nuclear background,
cybrids derived from either symptomatic or asymptomatic
mitochondria donors of the Chinese family exhibited nearly
identical average degrees of mitochondrial dysfunction. In
particular, the very signiﬁcant decrease in the rate of mito-
chondrial protein synthesis was observed in mutant cybrids
derived from three symptomatic or two asymptomatic indi-
viduals, as compared with the average rate in control cybrids.
These data strongly suggested that the C1494T mutation is the
primary factor responsible for impairing mitochondrial protein
synthesis.Furthermore,therewasavery signiﬁcantcorrelation
between the rate of mitochondrial protein synthesis, and over-
all respiratory capacity or the rate of malate/glutamate pro-
moted respiration, or succinate/G3P-promoted respiration, or
TMPD/ascorbate-promoted respiration in the control and mut-
ant cybrids derived from either symptomatic or asymptomatic
individuals. Indeed,  40% decreased rate of mitochondrial
protein synthesis caused by the C1494T mutation appears
to be responsible for a signiﬁcant reduction in respiration.
These reduced levels in cybrids carrying the C1494T mutation
are comparable with  35 and  37% average reduction in the
rate of mitochondrial protein labeling observed in cybrids
derived from matrilineal relatives of an Arab–Israeli family
carryingthe A1555Gmutation(35). However, 50%decrease
in the rate of mitochondrial protein synthesis was proposed to
be a threshold level to produce the deafness phenotype asso-
ciated with the A1555G mutation (36). Thus, the reduced rate
of mitochondrial protein synthesis in cybrids carrying the
C1494T mutation appears to be below the proposed threshold
level to support a normal respiratory phenotype (36). The
threshold level supporting a normal respiratory phenotype
was consistent with the evidence that a reduction of >50–
60% in the copy number of the tRNA genes comprised within
the 5 kb mtDNA deletion associated with chronic external
ophthalmoplegia (43), or with the Pearson syndrome (44),
or a 50–60% decrease in aminoacylation capacity of the mito-
chondrial tRNA
Lys associated with the MERRF-associated
A8344G mutation (45) produces a dramatic decrease in the
mitochondrial translation rate and respiratory capacity. In this
study, the fact that mild biochemical defects detected in mut-
ant cybrids cells may explain why only a portion of subjects
with the C1494T mutation developed hearing impairment in
this Chinese family (25). These data suggest that the C1494T
mutation alone is not sufﬁcient to produce the clinical pheno-
type and other factors including nuclear modiﬁer genes modu-
late the phenotypic manifestation of this mutation.
Our previous data indicated that the C1494T mutation led to
the sensitivity to aminoglycosides (25). Strikingly, the very
signiﬁcant/nearly identical increase in the ratio of DTs in
DMDM medium in the presence/absence of high concentra-
tion of paromomycin was observed in cybrids derived from
three symptomatic and two asymptomatic individuals carrying
the C1494T mutation, as compared with the average rate in
control cybrids. These results were in contrast to the fact that
there was a considerable variability in sensitivity to
aminoglycosides in lymphoblastoid cell lines derived from
two asymptomatic members and four symptomatic members
of the Chinese family carrying the C1494T mutation (25). In
fact, the reduced growth rate of mutant cybrids carrying the
C1494T mutation in media containing paromomycin is most
probably due to a worsening of mitochondrial translation and
subsequent respiration defect, as in the case of the cells
carrying the A1555G mutation (18,32). The observation
that variable degrees of sensitivity to aminoglycosides in
lymphoblastoid cell lines derived from asymptomatic and
symptomatic members of the Chinese family was signiﬁcantly
reduced by the transferring of mitochondria from matrilineal
relatives into the constant nuclear background of an mtDNA
less cell line is the ﬁrst direct evidence that the nuclear back-
ground plays a critical role in aminoglycoside toxicity asso-
ciated with the C1494T mutation. These data also strongly
indicated that sensitivity to aminoglycoside in cybrids under
a constant nuclear background is fully dependent on the pres-
ence of the mitochondrial 12S rRNA C1494T mutation.
Table 1 shows the aminglycoside sensitivity and mitochon-
drial defects detected in the previous studies of cybrids car-
rying the A1555G mutation and the present work for cybrids
carrying the C1494T mutation. In our previous investigation,
there were almost identical decreases of mitochondrial protein
labeling observed in cybrids derived from ﬁve symptomatic
and from three asymptomatic individuals of the Arab–Israeli
family carrying the A1555G mutation (35). In the present
work, similarly, almost identical average reductions in the
rate of mitochondrial protein synthesis have been found in
cybrids derived from three symptomatic and from two
asymptomatic individuals of the Chinese family carrying
Figure 6. Growth properties of cybrid cell lines. The population DTs during
4 days of growth was determined in the DMEM medium in the presence and
absenceofparomomycin.TheratiosofDTsinthepresenceandabsenceof2mg
paromomycin per ml are shown. A total of 4–6 determinations were made on
each of the three cybrids derived from each donor lymphoblastoid cell line.
Graph details and symbols are explained in the legend to Figure 3.
Nucleic Acids Research, 2005, Vol. 33, No. 3 1137the C1494T mutation. A comparison of the behavior of the
other parameters tested in cybrids carrying the A1555G muta-
tion and the C1494T mutation revealed the same trend and
comparable degrees of mitochondrial dysfunction and sensit-
ivity to aminoglycosides when compared with those of con-
trols. Therefore, our data provide the strong biochemical
evidence that the C1494T mutation is the novel pathogenic
mtDNA mutation associated with both aminoglycoside-
induced and non-syndromic hearing loss.
In summary, our ﬁndings convincingly demonstrate the
pathogenic mechanism leading to an impaired oxidative phos-
phorylation and aminoglycoside toxicity in cybrids carrying
the C1494T mutation. A signiﬁcant decrease in the rate of
mitochondrial protein synthesis, produced by the C1494T
mutation, is most probably a primary contributor for respirat-
ory phenotype in mutant cells, consequently resulting in
a decline in ATP production in the cochlear cells, which
are essential for the hearing function. However, incomplete
penetrance of hearing loss and mild biochemical defects
observed in this investigation strongly indicated that the
C1494T mutation itself is not sufﬁcient to produce a hearing-
impaired phenotype. Aminoglycosides modulate the
phenotypic expression of the C1494T mutation. Furthermore,
nuclear background plays a critical role in the phenotypic
manifestation of non-syndromic hearing loss and aminoglyc-
oside toxicity associated with the C1494T mutation.
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